ATMI to sell LifeSciences ops to Pall for $185M

|About: ATMI Inc. (ATMI)|By:, SA News Editor

ATMI (ATMI) has agreed to sell its LifeSciences unit to Pall Corp. (PLL) in a deal worth $185M, with after-tax proceeds to be $165M.

The sale is part of ATMI's "ongoing exploration of strategic alternatives," the company said.

The assets of the LifeSciences business include two Belgian sites and a shared facility in Minnesota. (PR)